awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36170691-8F626B7C-58B3-4203-91DD-DC07354B4BBA
Q36170691-8F626B7C-58B3-4203-91DD-DC07354B4BBA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36170691-8F626B7C-58B3-4203-91DD-DC07354B4BBA
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study.
P2860
Q36170691-8F626B7C-58B3-4203-91DD-DC07354B4BBA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36170691-8F626B7C-58B3-4203-91DD-DC07354B4BBA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
efd313c96e6e784c0bab8b3843473f6fbb536887
P2860
Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.